How to harness AI’s potential in research — responsibly and ethically
Artificial intelligence is propelling advances in all areas of science. But vigilance is needed, warn four researchers at the leading edge....
Artificial intelligence is propelling advances in all areas of science. But vigilance is needed, warn four researchers at the leading edge....
Dr. Howard Bailey came to the University of Wisconsin in 1988 as a medical oncology fellow fresh from medical school and residency. He knew his passion was cancer care and research, but he did not expect to stay at UW for very long....
A new podcast of the University of Wisconsin Carbone Cancer Center explores how inequities and barriers in cancer research, screening and health care create life-threatening disparities for many people in Wisconsin and beyond....
We use the latest clinical trial data to map out active site locations and understand how healthcare deserts are affecting clinical trial access in the United States, and how this can be addressed....
After a remarkable career as a compassionate, committed oncologist (and nine years as director at the Carbone Cancer Center), Howard Bailey is retiring....
Figuring out how to interconnect disparate systems and standardize data has always been a primary function of a data manager’s role. But in the past decade, the number of data points that need to be collected for a trial has grown exponentially....
Since 2015, Wisconsin has added over 15,000 new biohealth jobs, helping the industry workforce grow to more than 129,000...
The $268 million effort aims to elevate indigenous knowledge and culture in research to respond to the overdose crisis ...
A unique influenza vaccine candidate that’s inhaled and based on technology developed by University of Wisconsin–Madison researchers is safe and could bolster protection against seasonal and pandemic influenza....
Diversity in clinical research has become a hot topic in recent years, with heightened attention leading to dramatic changes in the regulatory framework, including U.S. legislation broadening the scope of diversity consideration in clinical trials....